All News

March 6, 2023

Cell-free hemoglobin in pulmonary hypertension

Cell-free hemoglobin generated by the lungs may be a therapeutic target for treating pulmonary arterial hypertension, Vanderbilt researchers found.

By Leigh MacMillan
March 2, 2023

Sex counts in the brain as seasons change

Photoperiod, or length of day, has sex-specific impacts on dopamine dynamics in the brain, offering insights into sex differences in neuropsychiatric disorders, Vanderbilt researchers report.

By Paul Govern
March 2, 2023

Sex-specific regulation of kidney signals

Links between estrogen signaling and sodium excretion by the kidney could help explain a reduced risk of hypertension in females versus males.

By Kelsey Pinckard
March 2, 2023

Eng invited to White House Cancer Moonshot forum

Vanderbilt’s Cathy Eng, MD, has been invited to participate in the White House Cancer Moonshot Colorectal Cancer Forum.

By Tom Wilemon
March 2, 2023

High-dose flu vaccine beneficial for pediatric stem cell transplant patients

Vanderbilt was the lead site for an influenza vaccine study in pediatric allogeneic hematopoietic stem cell transplant recipients that may lead to a change in the current flu vaccine recommendations in this vulnerable population.

By Jessica Pasley
February 27, 2023

Calm, cool and collected, Lamar Bowman shines in high-pressure situations

For his professionalism, kindness, patience and nursing skills, Bowman, assistant nurse manager, was recognized with a Credo Award.

By Kathy Whitney
February 27, 2023

Moberly extends impact of cochlear implantation research, quality of life outcomes

Vanderbilt's Aaron Moberly, MD, is developing an adult cochlear implant research/clinical program that aims to tailor rehabilitative treatment protocols to individual patients based on their auditory, linguistic and cognitive profiles.
By Danny Bonvissuto
February 23, 2023

2022 another strong year for Vanderbilt Transplant Center

By Matt Batcheldor
February 23, 2023

Bastarache takes on new role for research career development

Julie Bastarache, MD, has been appointed Assistant Vice President for Clinical & Translational Scientist Development at Vanderbilt University Medical Center.
By Leigh MacMillan
February 21, 2023

Diabetes drug may improve asthma

New biomarker finding strengthens the case for using GLP-1R agonists to treat patients with Type 2 diabetes who also suffer from asthma.
By Sarah E. Glass
February 20, 2023

Probing hellbender health

Understanding how hellbenders — large, fully aquatic salamanders — fight fungal pathogens and disease is important for protecting these unique stream predators; Vanderbilt researchers add new insights.
By Leigh MacMillan
February 16, 2023

Breast cancer genetics: new insights

Largest genetic study of breast cancer to date identifies 222 genetic risk loci, 137 genes and multiple signaling pathways associated with risk, providing important new insights.
By Leigh MacMillan
February 16, 2023

Targeted therapy for neuroendocrine tumors

Cancer therapies that target VEGF receptor appear safe and effective for patients with pancreatic and non-pancreatic neuroendocrine tumors, meta-analysis of phase 2/3 clinical trials demonstrates.
By Kelsey Pinckard